文献速递免疫规划传染病防控与疫情报告

欧洲老年人重复接种季节性流感疫苗:对实验室确诊住院流感的影响

Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.
PubMed 文献 · Vaccine · 2017-07-11

研究在11个欧洲国家的医院开展多中心检测阴性病例对照研究,纳入四个季节共5295例≥65岁患者,评估当前季节疫苗接种对实验室确诊住院流感的疫苗有效性(IVE)。结果显示,无论既往接种史,当前疫苗对A(H3N2)和B型住院流感提供一定保护;但既往两季均接种者当前疫苗对A(H1N1)pdm09似乎无效。

要点

  • 既往两季均未接种者,当前疫苗对A(H3N2)的IVE为8%(95%CI:-94至56)。
  • 既往两季均接种者,当前疫苗对A(H3N2)的IVE为37%(95%CI:7至57),对B型为43%(95%CI:1至68)。
  • 既往两季均接种者,当前疫苗对A(H1N1)pdm09的IVE为-1%(95%CI:-80至43)。

核心结论

  • 结果提示,无论患者近期接种史如何,当前季节疫苗对已接种患者抵抗A(H3N2)和B型住院流感提供一定保护。
  • 既往两季均接种的患者再接种当前疫苗对A(H1N1)pdm09似乎无效。
  • 需要开展记录疫苗暴露和自然感染暴露的大型队列研究,以更好地理解重复接种的效果。

研究设计与样本

  • 2011年至2014年及2015-16年,在11个欧洲国家的医院开展多中心检测阴性病例对照研究。
  • 研究对象为≥65岁、因流感相关临床状况入院且严重急性呼吸道感染发病≤7天的患者。
  • 病例为流感病毒RT-PCR阳性患者,对照为任何流感病毒阴性患者。
  • 记录当前季节及前两个季节的疫苗接种状态。
  • 四个季节共招募5295例患者,包括465例A(H1N1)pdm09、642例A(H3N2)、278例B型病例患者和3910例对照。

主要发现

  • 既往两季均未接种者,当前季节疫苗(合并季节)对A(H1N1)pdm09的IVE为30%(95%CI:-35至64)。
  • 既往两季均未接种者,当前季节疫苗(合并季节)对A(H3N2)的IVE为8%(95%CI:-94至56)。
  • 既往两季均未接种者,当前季节疫苗(合并季节)对B型的IVE为33%(95%CI:-43至68)。
  • 既往两季均接种者,当前季节疫苗(合并季节)对A(H1N1)pdm09的IVE为-1%(95%CI:-80至43)。
  • 既往两季均接种者,当前季节疫苗(合并季节)对A(H3N2)的IVE为37%(95%CI:7至57),对B型的IVE为43%(95%CI:1至68)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要开展记录疫苗暴露和自然感染暴露的大型队列研究,以更好地理解重复接种的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Europe, annual influenza vaccination is recommended to elderly. From 2011 to 2014 and in 2015-16, we conducted a multicentre test negative case control study in hospitals of 11 European countries to measure influenza vaccine effectiveness (IVE) against laboratory confirmed hospitalised influenza among people aged ≥65years. We pooled four seasons data to measure IVE by past exposures to influenza vaccination. We swabbed patients admitted for clinical conditions related to influenza with onset of severe acute respiratory infection ≤7days before admission. Cases were patients RT-PCR positive for influenza virus and controls those negative for any influenza virus. We documented seasonal vaccination status for the current season and the two previous seasons. We recruited 5295 patients over the four seasons, including 465A(H1N1)pdm09, 642A(H3N2), 278 B case-patients and 3910 controls. Among patients unvaccinated in both previous two seasons, current seasonal IVE (pooled across seasons) was 30% (95%CI: -35 to 64), 8% (95%CI: -94 to 56) and 33% (95%CI: -43 to 68) against influenza A(H1N1)pdm09, A(H3N2) and B respectively. Among patients vaccinated in both previous seasons, current seasonal IVE (pooled across seasons) was -1% (95%CI: -80 to 43), 37% (95%CI: 7-57) and 43% (95%CI: 1-68) against influenza A(H1N1)pdm09, A(H3N2) and B respectively. Our results suggest that, regardless of patients' recent vaccination history, current seasonal vaccine conferred some protection to vaccinated patients against hospitalisation with influenza A(H3N2) and B. Vaccination of patients already vaccinated in both the past two seasons did not seem to be effective against A(H1N1)pdm09. To better understand the effect of repeated vaccination, engaging in large cohort studies documenting exposures to vaccine and natural infection is needed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rondy M, Launay O, Castilla J, et al. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. Vaccine. 2017. PMID: 28709555. doi:10.1016/j.vaccine.2017.06.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。